HEADER OXIDOREDUCTASE 16-DEC-05 2DBZ TITLE CRYSTAL STRUCTURE OF GLYOXYLATE REDUCTASE (PH0597) FROM PYROCOCCUS TITLE 2 HORIKOSHII OT3, COMPLEXED WITH NADP (P61) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYOXYLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GLYCOLATE REDUCTASE, PH0597; COMPND 5 EC: 1.1.1.26; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 70601; SOURCE 4 STRAIN: OT3; SOURCE 5 GENE: PH0597; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS GLYOXYLATE REDUCTASE, D-3-PHOSPHOGLYCERATE DEHYDROGENASE, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.YOSHIKAWA,R.ARAI,Y.KINOSHITA,T.UCHIKUBO-KAMO,R.AKASAKA,T.TERADA, AUTHOR 2 M.SHIROUZU,S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 3 INITIATIVE (RSGI) REVDAT 6 25-OCT-23 2DBZ 1 REMARK REVDAT 5 13-JUL-11 2DBZ 1 VERSN REVDAT 4 09-JUN-09 2DBZ 1 REVDAT REVDAT 3 24-FEB-09 2DBZ 1 VERSN REVDAT 2 02-DEC-08 2DBZ 1 JRNL REVDAT 1 16-JUN-06 2DBZ 0 JRNL AUTH S.YOSHIKAWA,R.ARAI,Y.KINOSHITA,T.UCHIKUBO-KAMO,T.WAKAMATSU, JRNL AUTH 2 R.AKASAKA,R.MASUI,T.TERADA,S.KURAMITSU,M.SHIROUZU,S.YOKOYAMA JRNL TITL STRUCTURE OF ARCHAEAL GLYOXYLATE REDUCTASE FROM PYROCOCCUS JRNL TITL 2 HORIKOSHII OT3 COMPLEXED WITH NICOTINAMIDE ADENINE JRNL TITL 3 DINUCLEOTIDE PHOSPHATE. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 63 357 2007 JRNL REFN ISSN 0907-4449 JRNL PMID 17327673 JRNL DOI 10.1107/S0907444906055442 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 848916.650 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 37243 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3747 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5100 REMARK 3 BIN R VALUE (WORKING SET) : 0.3340 REMARK 3 BIN FREE R VALUE : 0.3880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 573 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5346 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.18000 REMARK 3 B22 (A**2) : -7.18000 REMARK 3 B33 (A**2) : 14.37000 REMARK 3 B12 (A**2) : 4.12000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.930 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.320 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 6.600 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.360 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 47.19 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SO4.PARAM REMARK 3 PARAMETER FILE 4 : NAP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : SO4.TOP REMARK 3 TOPOLOGY FILE 4 : NAP.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-DEC-05. REMARK 100 THE DEPOSITION ID IS D_1000025233. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI DOUBLE CRYSTAL REMARK 200 OPTICS : TWO DIMENSIONAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41156 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.236 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.7890 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.502 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2DBQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M POTASSIUM SODIUM TARTRATE PH 5.6, REMARK 280 0.1M SODIUM CITRATE, 2.0M AMMONIUM SULFATE, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.69300 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 121.38600 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 91.03950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 151.73250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 30.34650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -120.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 334 REMARK 465 GLU B 334 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 64 11.57 -61.39 REMARK 500 LEU A 68 107.92 -49.59 REMARK 500 TYR A 78 26.58 -148.28 REMARK 500 ASP A 98 -38.02 68.66 REMARK 500 LEU A 158 56.86 -93.73 REMARK 500 ALA A 211 46.27 -149.51 REMARK 500 ALA A 240 -91.50 -91.18 REMARK 500 ASN A 274 103.88 -161.90 REMARK 500 ARG A 329 148.50 -178.30 REMARK 500 ASP B 58 -159.40 -87.54 REMARK 500 TYR B 74 57.05 -98.27 REMARK 500 TYR B 78 27.50 -151.91 REMARK 500 ASP B 98 -40.13 69.93 REMARK 500 ALA B 211 44.63 -156.45 REMARK 500 ALA B 240 -88.93 -89.86 REMARK 500 ARG B 313 20.16 -71.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2DBQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN (SPACE GROUP I41) REMARK 900 RELATED ID: 2DBR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN (SPACE GROUP P1) REMARK 900 RELATED ID: PHO001000597.2 RELATED DB: TARGETDB DBREF 2DBZ A 1 334 UNP O58320 GYAR_PYRHO 1 334 DBREF 2DBZ B 1 334 UNP O58320 GYAR_PYRHO 1 334 SEQRES 1 A 334 MET LYS PRO LYS VAL PHE ILE THR ARG GLU ILE PRO GLU SEQRES 2 A 334 VAL GLY ILE LYS MET LEU GLU ASP GLU PHE GLU VAL GLU SEQRES 3 A 334 VAL TRP GLY ASP GLU LYS GLU ILE PRO ARG GLU ILE LEU SEQRES 4 A 334 LEU LYS LYS VAL LYS GLU VAL ASP ALA LEU VAL THR MET SEQRES 5 A 334 LEU SER GLU ARG ILE ASP LYS GLU VAL PHE GLU ASN ALA SEQRES 6 A 334 PRO LYS LEU ARG ILE VAL ALA ASN TYR ALA VAL GLY TYR SEQRES 7 A 334 ASP ASN ILE ASP ILE GLU GLU ALA THR LYS ARG GLY ILE SEQRES 8 A 334 TYR VAL THR ASN THR PRO ASP VAL LEU THR ASP ALA THR SEQRES 9 A 334 ALA ASP LEU ALA PHE ALA LEU LEU LEU ALA THR ALA ARG SEQRES 10 A 334 HIS VAL VAL LYS GLY ASP ARG PHE VAL ARG SER GLY GLU SEQRES 11 A 334 TRP LYS LYS ARG GLY VAL ALA TRP HIS PRO LYS TRP PHE SEQRES 12 A 334 LEU GLY TYR ASP VAL TYR GLY LYS THR ILE GLY ILE ILE SEQRES 13 A 334 GLY LEU GLY ARG ILE GLY GLN ALA ILE ALA LYS ARG ALA SEQRES 14 A 334 LYS GLY PHE ASN MET ARG ILE LEU TYR TYR SER ARG THR SEQRES 15 A 334 ARG LYS GLU GLU VAL GLU ARG GLU LEU ASN ALA GLU PHE SEQRES 16 A 334 LYS PRO LEU GLU ASP LEU LEU ARG GLU SER ASP PHE VAL SEQRES 17 A 334 VAL LEU ALA VAL PRO LEU THR ARG GLU THR TYR HIS LEU SEQRES 18 A 334 ILE ASN GLU GLU ARG LEU LYS LEU MET LYS LYS THR ALA SEQRES 19 A 334 ILE LEU ILE ASN ILE ALA ARG GLY LYS VAL VAL ASP THR SEQRES 20 A 334 ASN ALA LEU VAL LYS ALA LEU LYS GLU GLY TRP ILE ALA SEQRES 21 A 334 GLY ALA GLY LEU ASP VAL PHE GLU GLU GLU PRO TYR TYR SEQRES 22 A 334 ASN GLU GLU LEU PHE LYS LEU ASP ASN VAL VAL LEU THR SEQRES 23 A 334 PRO HIS ILE GLY SER ALA SER PHE GLY ALA ARG GLU GLY SEQRES 24 A 334 MET ALA GLU LEU VAL ALA LYS ASN LEU ILE ALA PHE LYS SEQRES 25 A 334 ARG GLY GLU ILE PRO PRO THR LEU VAL ASN ARG GLU VAL SEQRES 26 A 334 ILE LYS ILE ARG LYS PRO GLY PHE GLU SEQRES 1 B 334 MET LYS PRO LYS VAL PHE ILE THR ARG GLU ILE PRO GLU SEQRES 2 B 334 VAL GLY ILE LYS MET LEU GLU ASP GLU PHE GLU VAL GLU SEQRES 3 B 334 VAL TRP GLY ASP GLU LYS GLU ILE PRO ARG GLU ILE LEU SEQRES 4 B 334 LEU LYS LYS VAL LYS GLU VAL ASP ALA LEU VAL THR MET SEQRES 5 B 334 LEU SER GLU ARG ILE ASP LYS GLU VAL PHE GLU ASN ALA SEQRES 6 B 334 PRO LYS LEU ARG ILE VAL ALA ASN TYR ALA VAL GLY TYR SEQRES 7 B 334 ASP ASN ILE ASP ILE GLU GLU ALA THR LYS ARG GLY ILE SEQRES 8 B 334 TYR VAL THR ASN THR PRO ASP VAL LEU THR ASP ALA THR SEQRES 9 B 334 ALA ASP LEU ALA PHE ALA LEU LEU LEU ALA THR ALA ARG SEQRES 10 B 334 HIS VAL VAL LYS GLY ASP ARG PHE VAL ARG SER GLY GLU SEQRES 11 B 334 TRP LYS LYS ARG GLY VAL ALA TRP HIS PRO LYS TRP PHE SEQRES 12 B 334 LEU GLY TYR ASP VAL TYR GLY LYS THR ILE GLY ILE ILE SEQRES 13 B 334 GLY LEU GLY ARG ILE GLY GLN ALA ILE ALA LYS ARG ALA SEQRES 14 B 334 LYS GLY PHE ASN MET ARG ILE LEU TYR TYR SER ARG THR SEQRES 15 B 334 ARG LYS GLU GLU VAL GLU ARG GLU LEU ASN ALA GLU PHE SEQRES 16 B 334 LYS PRO LEU GLU ASP LEU LEU ARG GLU SER ASP PHE VAL SEQRES 17 B 334 VAL LEU ALA VAL PRO LEU THR ARG GLU THR TYR HIS LEU SEQRES 18 B 334 ILE ASN GLU GLU ARG LEU LYS LEU MET LYS LYS THR ALA SEQRES 19 B 334 ILE LEU ILE ASN ILE ALA ARG GLY LYS VAL VAL ASP THR SEQRES 20 B 334 ASN ALA LEU VAL LYS ALA LEU LYS GLU GLY TRP ILE ALA SEQRES 21 B 334 GLY ALA GLY LEU ASP VAL PHE GLU GLU GLU PRO TYR TYR SEQRES 22 B 334 ASN GLU GLU LEU PHE LYS LEU ASP ASN VAL VAL LEU THR SEQRES 23 B 334 PRO HIS ILE GLY SER ALA SER PHE GLY ALA ARG GLU GLY SEQRES 24 B 334 MET ALA GLU LEU VAL ALA LYS ASN LEU ILE ALA PHE LYS SEQRES 25 B 334 ARG GLY GLU ILE PRO PRO THR LEU VAL ASN ARG GLU VAL SEQRES 26 B 334 ILE LYS ILE ARG LYS PRO GLY PHE GLU HET SO4 A 502 5 HET SO4 A 504 5 HET NAP A 401 48 HET SO4 B 501 5 HET SO4 B 503 5 HET NAP B 402 48 HETNAM SO4 SULFATE ION HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 NAP 2(C21 H28 N7 O17 P3) FORMUL 9 HOH *73(H2 O) HELIX 1 1 PRO A 12 ASP A 21 1 10 HELIX 2 2 PRO A 35 VAL A 43 1 9 HELIX 3 3 ASP A 58 ASN A 64 1 7 HELIX 4 4 ASP A 82 ARG A 89 1 8 HELIX 5 5 LEU A 100 HIS A 118 1 19 HELIX 6 6 HIS A 118 SER A 128 1 11 HELIX 7 7 GLY A 129 GLY A 135 1 7 HELIX 8 8 GLY A 159 PHE A 172 1 14 HELIX 9 9 LYS A 184 ASN A 192 1 9 HELIX 10 10 PRO A 197 SER A 205 1 9 HELIX 11 11 ASN A 223 MET A 230 1 8 HELIX 12 12 ARG A 241 VAL A 245 5 5 HELIX 13 13 ASP A 246 GLY A 257 1 12 HELIX 14 14 ASN A 274 LEU A 280 1 7 HELIX 15 15 SER A 293 ARG A 313 1 21 HELIX 16 16 GLU A 324 ARG A 329 1 6 HELIX 17 17 PRO B 12 ASP B 21 1 10 HELIX 18 18 PRO B 35 VAL B 43 1 9 HELIX 19 19 ASP B 58 ASN B 64 1 7 HELIX 20 20 ASP B 82 ARG B 89 1 8 HELIX 21 21 LEU B 100 HIS B 118 1 19 HELIX 22 22 HIS B 118 SER B 128 1 11 HELIX 23 23 GLY B 129 ARG B 134 1 6 HELIX 24 24 GLY B 159 GLY B 171 1 13 HELIX 25 25 LYS B 184 ASN B 192 1 9 HELIX 26 26 PRO B 197 SER B 205 1 9 HELIX 27 27 GLU B 225 MET B 230 1 6 HELIX 28 28 ARG B 241 VAL B 245 5 5 HELIX 29 29 ASP B 246 GLU B 256 1 11 HELIX 30 30 ASN B 274 LEU B 280 1 7 HELIX 31 31 SER B 293 ARG B 313 1 21 HELIX 32 32 GLU B 324 ARG B 329 1 6 SHEET 1 A 5 GLU A 24 VAL A 27 0 SHEET 2 A 5 LYS A 4 ILE A 7 1 N ILE A 7 O GLU A 26 SHEET 3 A 5 ALA A 48 THR A 51 1 O ALA A 48 N LYS A 4 SHEET 4 A 5 ILE A 70 ASN A 73 1 O ALA A 72 N LEU A 49 SHEET 5 A 5 TYR A 92 THR A 94 1 O TYR A 92 N VAL A 71 SHEET 1 B 7 ALA A 193 PHE A 195 0 SHEET 2 B 7 ARG A 175 TYR A 179 1 N ILE A 176 O GLU A 194 SHEET 3 B 7 THR A 152 ILE A 156 1 N ILE A 153 O LEU A 177 SHEET 4 B 7 PHE A 207 LEU A 210 1 O PHE A 207 N GLY A 154 SHEET 5 B 7 ILE A 235 ASN A 238 1 O ILE A 237 N VAL A 208 SHEET 6 B 7 GLY A 261 LEU A 264 1 O GLY A 263 N LEU A 236 SHEET 7 B 7 VAL A 283 LEU A 285 1 O VAL A 284 N LEU A 264 SHEET 1 C 5 GLU B 24 VAL B 27 0 SHEET 2 C 5 LYS B 4 ILE B 7 1 N ILE B 7 O GLU B 26 SHEET 3 C 5 ALA B 48 THR B 51 1 O ALA B 48 N LYS B 4 SHEET 4 C 5 ILE B 70 ASN B 73 1 O ALA B 72 N LEU B 49 SHEET 5 C 5 TYR B 92 THR B 94 1 O TYR B 92 N VAL B 71 SHEET 1 D 7 ALA B 193 PHE B 195 0 SHEET 2 D 7 ARG B 175 TYR B 179 1 N ILE B 176 O GLU B 194 SHEET 3 D 7 THR B 152 ILE B 156 1 N ILE B 153 O LEU B 177 SHEET 4 D 7 PHE B 207 LEU B 210 1 O PHE B 207 N GLY B 154 SHEET 5 D 7 ILE B 235 ASN B 238 1 O ILE B 237 N VAL B 208 SHEET 6 D 7 GLY B 261 LEU B 264 1 O GLY B 263 N LEU B 236 SHEET 7 D 7 VAL B 283 LEU B 285 1 O VAL B 284 N LEU B 264 CISPEP 1 GLU A 270 PRO A 271 0 -0.07 CISPEP 2 GLU B 270 PRO B 271 0 -0.12 SITE 1 AC1 4 TYR B 78 ASN B 95 ARG B 160 HOH B 530 SITE 1 AC2 3 TYR A 78 ASN A 95 ARG A 160 SITE 1 AC3 8 LEU B 53 ALA B 75 VAL B 76 GLY B 77 SITE 2 AC3 8 ARG B 241 HIS B 288 SER B 291 NAP B 402 SITE 1 AC4 9 LEU A 53 ALA A 75 VAL A 76 GLY A 77 SITE 2 AC4 9 LEU A 100 ARG A 241 HIS A 288 SER A 291 SITE 3 AC4 9 NAP A 401 SITE 1 AC5 24 LYS A 42 VAL A 76 GLY A 77 THR A 104 SITE 2 AC5 24 LEU A 158 GLY A 159 ARG A 160 ILE A 161 SITE 3 AC5 24 SER A 180 ARG A 181 THR A 182 ALA A 211 SITE 4 AC5 24 PRO A 213 GLU A 217 THR A 218 ILE A 239 SITE 5 AC5 24 ALA A 240 ARG A 241 ASP A 265 HIS A 288 SITE 6 AC5 24 GLY A 290 SER A 291 SO4 A 504 HOH A 512 SITE 1 AC6 27 LYS B 42 VAL B 76 GLY B 77 THR B 104 SITE 2 AC6 27 GLY B 157 LEU B 158 GLY B 159 ARG B 160 SITE 3 AC6 27 ILE B 161 SER B 180 ARG B 181 THR B 182 SITE 4 AC6 27 ALA B 211 VAL B 212 PRO B 213 GLU B 217 SITE 5 AC6 27 THR B 218 ILE B 239 ALA B 240 ARG B 241 SITE 6 AC6 27 ASP B 265 HIS B 288 GLY B 290 SER B 291 SITE 7 AC6 27 SO4 B 503 HOH B 510 HOH B 530 CRYST1 104.472 104.472 182.079 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009572 0.005526 0.000000 0.00000 SCALE2 0.000000 0.011053 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005492 0.00000